SFVAHCS to begin COVID-19 vaccine clinical trial - San Francisco VA Health Care System
Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.

San Francisco VA Health Care System

 

SFVAHCS to begin COVID-19 vaccine clinical trial

Image of solicitation for vaccine trial volunteers

The San Francisco VA Health Care System is seeking Veterans and non-Veteran health care workers to participate in its COVID-19 vaccine trial.

Monday, November 9, 2020

On Nov. 12, the San Francisco VA Health Care System (SFVAHCS) will begin a clinical trial for a single-dose COVID-19 vaccine developed by the Janssen Pharmaceutical Companies of Johnson & Johnson. SFVAHCS is one of 17 VA sites nationwide participating in the Janssen trial.

SFVAHCS researchers are seeking 400 Veterans and non-Veteran health care workers - men and non-pregnant women over age 18 - to participate in the study, which is expected to enroll participants from November through the beginning of next year at the San Francisco VA Medical Center. Researchers are particularly interested in Black, Hispanic and Native American volunteers, as these communities have been hit especially hard by the COVID-19 pandemic. Those wanting to participate in the study may volunteer by submitting their names at www.va.gov/coronavirus-research.  

“It is critical that we identify a COVID-19 vaccine that is safe and effective in a clinical trial setting, and to provide our Veterans the opportunity to participate in this vitally important study,” said Dr. Phyllis Tien, who’s leading the trial at SFVAHCS. “The SFVAHCS has been a leader in the management of viral infections, including HIV and Hepatitis C. Investigation of COVID-19 therapeutics and vaccines fits within our mission.”

FREQUENTLY ASKED QUESTIONS

Can I get COVID-19 from the investigational vaccine?

You cannot get COVID-19 from the investigational vaccine or the placebo used as part of the study. The investigational vaccine does not contain any live or killed virus. For more information about the Janssen clinical trials, including the investigational vaccine they’re testing, visit www.ensemblestudy.com.

Will the investigational vaccine put me at a higher risk for getting COVID-19?

The investigational vaccine will not increase your risk of getting COVID-19. According to the Centers for Disease Control and Prevention (CDC), everyone is at risk for getting COVID-19 if they are exposed to the virus. However, some people are more likely to become more seriously ill than others, such as older adults and people with underlying health conditions. The investigational vaccine will not increase your risk of complications if you are diagnosed with COVID-19.

How can I sign up for this study?

Anyone interested in participating in the Janssen COVID-19 vaccine clinical trial at the San Francisco VA Medical Center should sign up on VA’s coronavirus research volunteer list at www.va.gov/coronavirus-research. Signing up on the volunteer list does not guarantee enrollment into the trial. Volunteers will be contacted if they meet the trial’s eligibility criteria.

Veterans who live too far from the San Francisco VA Medical Center, but want to volunteer for other COVID-19 vaccine clinical trials in their area, can register with the Coronavirus Prevention Network at www.coronaviruspreventionnetwork.org.

To learn more about other VA research efforts on COVID-19, visit https://www.research.va.gov/covid-19.cfm.

Share



Get Updates

Subscribe to Receive
Email Updates